R. López-Castañares
Universidad Autónoma del Estado de México
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by R. López-Castañares.
The Open Medicinal Chemistry Journal | 2013
V.H. Vázquez-Valadez; Víctor H. Abrego; Pablo A Martínez; Gabriela Torres; Oscar Zúñiga; Daniel Escutia; Rebeca Vilchis; Ana Ma. Velázquez; Luisa Martínez; Mónica Ruiz; Brígida Camacho; R. López-Castañares; Enrique Angeles
A main target in the treatment of hypertension is the angiotensin-converting enzyme (ACE). This enzyme is responsible for producing angiotensin II, a potent vasoconstrictor. Therefore, one of the targets in the treatment of hypertension is to inhibit ACE activity. Hence, this study’s aim is to use computational studies to demonstrate that the proposed heterocyclic compounds have a molecular affinity for ACE and that, furthermore, these heterocyclic compounds are capable of inhibiting ACE activity, thus avoiding the production of the vasopressor Angiotensin II. All this using computer-aided drug design, and studying the systems, with the proposed compounds, through molecular recognition process and compared with the compounds already on the market for hypertension.
Molbank | 2007
Ana María Velázquez; Luis Alberto Torres; Raúl C Praderi González; A. Valencia; Sandra Díaz-Barriga; Italo Menconi; Luisa Martínez; Alberto Ramírez; Ignacio Díaz Martínez; Brígida Camacho; R. López-Castañares; Enrique Angeles
Infrared light activation as a non-conventional energy source has become an important method that can be used to carry out a wide range of reactions with short reaction times and high yields.
Molbank | 2007
Enrique Angeles; Italo Menconi; Alberto Ramírez; Ana María Velázquez; Brígida Camacho; Gerardo Ordónez; Ignacio Díaz Martínez; Sandra Díaz-Barriga; R. López-Castañares
Radioprotectors have been described as a chemical compounds that protect certain normal tissues as opposed to tumors.[...]
Molbank | 2007
A. Ma. Velázquez; L. Torres; Raúl C Praderi González; A. Valencia; L Menconi; Luisa Martínez; Alberto Ramírez; Brígida Camacho; Sandra Díaz-Barriga; R. López-Castañares; Enrique Angeles
4-isopropyl-bis-2,6-morpholin-4-ylmethyl-1-phenol (2) was prepared from 4-isopropylphenol (1) and formaldehyde (2 eq.) and 2 eq. of morpholine.[...]
Molbank | 2007
Ana María Velázquez; Luis Alberto Torres; Raúl C Praderi González; A. Valencia; Sandra Díaz-Barriga; Italo Menconi; Luisa Martínez; Alberto Ramírez; Ignacio Díaz Martínez; Brígida Camacho; R. López-Castañares; Enrique Angeles
4-bromo-2-thiomorpholin-4-ylmethyl-1-phenol (2) was prepared from 4-bromophenol (1) and thiomorpholine and formaldehyde (2 eq.) and 1 eq. of thiomorpholine.[...]
Molbank | 2005
A. Ma. Velázquez; L. Torres; R. Gonzále; I. Martínez; A. Valencia; A. Pecin; I. Mencon; Luisa Martínez; Alberto Ramírez; R. Hernández; R. López-Castañares; O. Olvera-Neria; Enrique Angeles
4-tert-butyl-2-(thiomorpholin-4-ylmethyl)phenol (2) and 4-tert-butyl-2,6-bis(thiomorpholin-4-ylmethyl)phenol (3) were prepared from 4-tert-butylphenol (1) and thiomorpholine and formaldehyde (37%) in methanol as solvent.[...]
Molbank | 2005
A. Ma. Velázquez; L. Torres; Raúl C Praderi González; A. Valencia; A. Pecina; I. Menconi; I. Martínez; Luisa Martínez; Alberto Ramírez; R. Hernández; R. López-Castañares; O. Olvera-Neria; Enrique Angeles
4-chloro-2-(thiomorpholin-4-ylmethyl)phenol (2) was prepared from 4-chlorophenol (1) and thiomorpholine and formaldehyde (37%) in methanol as solvent.[...]
Molbank | 2005
A. Ma. Velázquez; L. Torres; Raúl C Praderi González; A. Valencia; I. Martínez; A. Pecina; I. Menconi; Luisa Martínez; Alberto Ramírez; R. Hernández; R. López-Castañares; O. Olvera-Neria; Enrique Angeles
4,6-bis(thiomorpholin-4-ylmethyl)-1,2,3-benzenetriol (2) was prepared from pyrogalol (1) and thiomorpholine and formaldehyde (37%) in methanol as solvent.[...]
Letters in Drug Design & Discovery | 2005
Enrique Angeles; Victor HugoVazquez-Valadez; Oscar Vazquez-Valadez; Ana María Velázquez-Sánchez; Alberto Ramírez; Luisa Martínez; Sandra Díaz-Barriga; Andres Romero-Rojas; Gustavo Cabrera; R. López-Castañares; Alfonso Dueñas-González
European Journal of Medicinal Chemistry | 2008
A. Ma. Velázquez; Luisa Martínez; Víctor H. Abrego; M.A.Balboa; Luis Alberto Torres; Brígida Camacho; Sandra Díaz-Barriga; A. Romero; R. López-Castañares; Enrique Angeles